Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
23
LABU Quote, Financials, Valuation and Earnings
Last price:
$37.83
Seasonality move
:
24.76%
Day range:
$32.55 - $47.59
52-week range:
$32.55 - $152.60
Dividend yield:
0.56%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
7.9M
Avg. volume:
1.7M
1-year change:
-61.28%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Direxion Daily S&P Biotech Bull 3X Shares has -- downside to fair value with a price target of -- per share.
LABU vs. S&P 500
-
Over the past 5 trading days, Direxion Daily S&P Biotech Bull 3X Shares has underperformed the S&P 500 by -28.47% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Direxion Daily S&P Biotech Bull 3X Shares does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Direxion Daily S&P Biotech Bull 3X Shares has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Direxion Daily S&P Biotech Bull 3X Shares reported revenues of --.
Earnings Growth
-
Direxion Daily S&P Biotech Bull 3X Shares has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Direxion Daily S&P Biotech Bull 3X Shares reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-10 | 2024-04-10 | 2024-04-10 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-04-10 | 2022-04-10 | 2023-04-10 | 2024-04-10 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-10 | 2024-04-10 | 2024-04-10 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
LABU
Sector
Market Cap
--
--
Price % of 52-Week High
29.96%
--
Dividend Yield
0.56%
--
Shareholder Yield
--
--
1-Year Price Total Return
-61.28%
--
Beta (5-Year)
3.007
--
Dividend yield:
0.56%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$49.92
200-day SMA
Sell
Level
$109.74
Bollinger Bands (100)
Sell
Level
71.46 - 111.28
Chaikin Money Flow
Buy
Level
6.1M
20-day SMA
Sell
Level
$65.14
Relative Strength Index (RSI14)
Sell
Level
33.25
ADX Line
Sell
Level
37.93
Williams %R
Neutral
Level
-73.051
50-day SMA
Sell
Level
$78.43
MACD (12, 26)
Sell
Level
-10.12
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
18.3M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (2)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, LABU has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LABU average analyst price target in the past 3 months is --.
-
Where Will Direxion Daily S&P Biotech Bull 3X Shares Stock Be In 1 Year?
According to analysts, the consensus estimate is that Direxion Daily S&P Biotech Bull 3X Shares share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Direxion Daily S&P Biotech Bull 3X Shares?
Analysts are divided on their view about Direxion Daily S&P Biotech Bull 3X Shares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Direxion Daily S&P Biotech Bull 3X Shares is a Sell and believe this share price will rise from its current level to --.
-
What Is Direxion Daily S&P Biotech Bull 3X Shares's Price Target?
The price target for Direxion Daily S&P Biotech Bull 3X Shares over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LABU A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Direxion Daily S&P Biotech Bull 3X Shares is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LABU?
You can purchase shares of Direxion Daily S&P Biotech Bull 3X Shares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Direxion Daily S&P Biotech Bull 3X Shares shares.
-
What Is The Direxion Daily S&P Biotech Bull 3X Shares Share Price Today?
Direxion Daily S&P Biotech Bull 3X Shares was last trading at $37.83 per share. This represents the most recent stock quote for Direxion Daily S&P Biotech Bull 3X Shares. Yesterday, Direxion Daily S&P Biotech Bull 3X Shares closed at $45.72 per share.
-
How To Buy Direxion Daily S&P Biotech Bull 3X Shares Stock Online?
In order to purchase Direxion Daily S&P Biotech Bull 3X Shares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
33
BULZ alert for Apr 10
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 18.2% over the past day.
Sell
31
TECS alert for Apr 10
Direxion Daily Technology Bear 3x Shares [TECS] is up 15.07% over the past day.
Sell
48
FNGA alert for Apr 10
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 14.71% over the past day.
